You have no items in your shopping cart.
Description
Research Area
Images & Validation
−
| Application Notes |
|---|
Key Properties
−| Expression System | HEK293 |
|---|---|
| Target | Her2 |
| Reactivity | Human |
| Tag | C-10×His |
| Expression Region | Thr 23 - Ala 510 |
| Endotoxins | 1.0 EU per μg |
| Conjugation | Unconjugated |
| MW | 55.6 kDa |
| Purity | 95% |
Storage & Handling
−| Storage | -20°C |
|---|---|
| Form/Appearance | Powder |
| Buffer/Preservatives | PBS, pH 7.4 |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Similar Products
−Recombinant human ErbB2 / Her2 protein, C-His-Avi (HEK293) [orb1516438]
>95% as determined by Tris-Bis PAGE; >95% as determined by SEC-HPLC
Due to glycosylation, the protein migrates to 80-100 kDa based on Tris-Bis PAGE result.
50 μgHuman Her2 Protein, His Tag [orb689435]
Unconjugated
The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining.
The protein has a predicted molecular mass of 70.2 kDa after removal of the signal peptide.The apparent molecular mass of Her2-His is approximately 100-130 kDa due to glycosylation.
Mammalian
100 μg, 50 μg, 10 μgRecombinant human ErbB3 / Her3 protein, C-His-Avi (HEK293) [orb1516436]
>95% as determined by Tris-Bis PAGE; >95% as determined by SEC-HPLC
Due to glycosylation, the protein migrates to 90-100 kDa based on Tris-Bis PAGE result.
100 μgRecombinant human HER2 protein, N-His [orb1808074]
>90% as determined by SDS-PAGE
40.7 kDa
100 μg, 500 μg, 20 μgRecombinant Human CD340/ERBB2 Protein, C-His [orb2969539]
ELISA, SDS-PAGE, WB
>90% as determined by SDS-PAGE.
72.84 kDa
1 mg, 50 μg, 100 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].










